Life Science Innovation on Single Cell Analysis continues: Single Cell Technologies and their Fields of Application (Tumor Cells)

Life Science Innovation on Single Cell Analysis continues: Single Cell Technologies and their Fields of Application (Tumor Cells)

With ‘Trends in Single Cell Analysis #2’ the University Hospital Düsseldorf, LifeScienceNet Düsseldorf and Life Science Center Düsseldorf will continue the event format ‘Life Science Innovation’, which provides insights into innovative research topics and current developments in Dusseldorf and NRW.

Single cell analysis allows the generation of comprehensive and precise data on the molecular composition and functional potential of individual cells. Precision medicine and targeted therapies as well as liquid biopsy and single cell analytics are the focus of current translational research. These technologies offer great potential not only for basic research, but also for medical and biotechnological applications.

This webinar’s topic will be the application of diagnostic leukapheresis (DLA) – a technology developed in Dusseldorf. DLA enables the clinically safe recovery of large numbers of viable and intact circulating tumor cell (CTC) populations from cancer patients, facilitating their comprehensive molecular and functional cancer cell characterization.

The invited speakers from academia and companies will give an overview on the use of DLA and CTCs in clinical and translational CTC-research.

The online event will be held on Wednesday, September 8th, 2021, from 4:00 to 6:00 p.m.
It will be presented in English. Participation is free of charge.

For participation please register using the form via the link below:

Registration is open until September 7th, 2021.


Welcoming speech
Dr. Thomas Heck, Life Science Center Düsseldorf
Prof. Dr. Nikolas Stoecklein, MD, Düsseldorf University Hospital

Moderation: Prof. Dr. Nikolas Stoecklein, Düsseldorf University Hospital

The potential of analysing Circulating Tumor Cells using Diagnostic Leukapheresis in prostate cancer patients
Martijn Lolkema, MD/PhD, Erasmus MC Cancer Institute in Rotterdam

Genomic and epi-genomic high-resolution profiling of single cells
Rui Neves, PhD, Düsseldorf University Hospital

A Proof of Concept Study for the Clinical Use of Circulating Tumor Cells
André Franken, PhD, Düsseldorf University Hospital

Moderation: Prof. Dr. Hans Neubauer, PhD, Düsseldorf University Hospital

Developments in Single Cell Analysis and Clinical Utility
Tim Pitfield, Menarini Silicon Biosystems

Comprehensive Profiling of Tumor and Their Microenvironment by Advanced Single Cell Sequencing Technologies
Nan Fang, PhD, MBA, Singleron Biotechnologies

div#stuning-header .dfd-stuning-header-bg-container {background-image: url(;background-size: cover;background-position: top center;background-attachment: scroll;background-repeat: initial;}#stuning-header {min-height: 550px;}#main-content .dfd-content-wrap {margin: 0px;} #main-content .dfd-content-wrap > article {padding: 0px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width >,#layout.dfd-gallery-loop > .row.full-width > {padding: 0 0px;}#layout.dfd-portfolio-loop > .row.full-width > > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > > #main-content > .dfd-content-wrap:first-child {border-top: 0px solid transparent; border-bottom: 0px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 0px;padding-bottom: 0px;}#layout.dfd-portfolio-loop > .row.full-width > .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .sort-panel {margin-left: -0px;margin-right: -0px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}